LEO Pharma’s Anzupgo cream to treat chronic hand eczema receives marketing approval in Switzerland: Ballerup, Denmark Saturday, November 16, 2024, 15:00 Hrs [IST] LEO Pharma A/S ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Anzupgo is the first topical pan-Janus kinase (JAK) inhibitor to be approved in Switzerland specifically for moderate to ...

We’re exploring practical ways to manage eczema flare-ups at work, so you can stay comfortable, focused, and as stress-free ...

Both body creams and lotions hydrate skin, but they have a few key differences. The main is consistency. Here’s how to tell ...

Eczema on the legs may be treated differently depending on which part of the leg is affected. Lower leg eczema, also called varicose eczema or stasis eczema, affects about 70% of people over 70.

The indication is for the treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inadequate ...

NEW YORK, Nov. 13 (UPI) --Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed skin, a new study suggests. The study was ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

The term "protein contact dermatitis" was coined by Hjorth and Roed-Petersen in 1976 [1] to describe the condition of several food handlers with hand and forearm eczema. The responsible allergen ...